标题
Targeting survivin as a potential new treatment for chondrosarcoma of bone
作者
关键词
-
出版物
Oncogenesis
Volume 5, Issue 5, Pages e222-e222
出版商
Springer Nature
发表日期
2016-05-09
DOI
10.1038/oncsis.2016.33
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancers
- (2015) Neha Singh et al. DRUG DISCOVERY TODAY
- Mesenchymal chondrosarcoma: Prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study
- (2015) Anna Maria Frezza et al. EUROPEAN JOURNAL OF CANCER
- Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells
- (2015) Caroline van Haaften et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma
- (2015) Zuzanna Baranski et al. JOURNAL OF PATHOLOGY
- Survivin – The inconvenient IAP
- (2015) Dario C. Altieri SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial–mesenchymal transition via ERK and PI3K/AKT pathway
- (2014) Peng Yang et al. MEDICAL ONCOLOGY
- Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma
- (2014) S N Brun et al. ONCOGENE
- Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGFβ as Potential Targets
- (2013) Jolieke G. van Oosterwijk et al. AMERICAN JOURNAL OF PATHOLOGY
- Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells
- (2013) J G van Oosterwijk et al. BRITISH JOURNAL OF CANCER
- Clinico-pathologic relevance of Survivin splice variant expression in cancer
- (2013) Rosalia de Necochea-Campion et al. CANCER LETTERS
- Functional Profiling of Receptor Tyrosine Kinases and Downstream Signaling in Human Chondrosarcomas Identifies Pathways for Rational Targeted Therapy
- (2013) Y.-X. Zhang et al. CLINICAL CANCER RESEARCH
- Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
- (2012) Jolieke G van Oosterwijk et al. BMC CANCER
- MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
- (2012) Sidong Huang et al. CELL
- Interleukin Enhancer-binding Factor 3/NF110 Is a Target of YM155, a Suppressant of Survivin
- (2012) Naoto Nakamura et al. MOLECULAR & CELLULAR PROTEOMICS
- Characterization of a New Human Cell Line (CH-3573) Derived from a Grade II Chondrosarcoma with Matrix Production
- (2012) Silvia Calabuig-Fariñas et al. PATHOLOGY & ONCOLOGY RESEARCH
- Inhibition of Chondrosarcoma Growth by mTOR Inhibitor in an In Vivo Syngeneic Rat Model
- (2012) Jennifer Perez et al. PLoS One
- Survivin Is a Therapeutic Target in Merkel Cell Carcinoma
- (2012) R. Arora et al. Science Translational Medicine
- Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance
- (2011) J. G. van Oosterwijk et al. ANNALS OF ONCOLOGY
- The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro
- (2011) Philipp Lechler et al. BMC CANCER
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR
- (2011) Anastasia Pavlidou WORLD JOURNAL OF GASTROENTEROLOGY
- Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models
- (2010) Takahito Nakahara et al. CANCER SCIENCE
- Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment
- (2009) Y. M. Schrage et al. CANCER RESEARCH
- Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet effort
- (2009) Laura Ottaviano et al. GENES CHROMOSOMES & CANCER
- Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults
- (2008) Tobias M. Dantonello et al. CANCER
- Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study
- (2008) Isidro Machado et al. Diagnostic Pathology
- Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro
- (2008) Yvonne M. Schrage et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Clinical Approach Towards Chondrosarcoma
- (2008) H. Gelderblom et al. ONCOLOGIST
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started